CBG is a non-intoxicating cannabis compound whose full name is cannabigerol. It has been gathering attention for its promising effects in the treatment of a wide variety of medical conditions.
According to multiple studies from researchers investigating its potential as a palliative, CBG works to fight inflammation, pain and nausea, and is showing potential in terms of slowing the proliferation of cancer cells. Research has shown it also significantly lowers the intraocular eye pressure caused by glaucoma. Strains high in CBG also could be beneficial for treating conditions such as inflammatory bowel disease, Crohn’s disease and cancer.
In cannabis plants, CBG is essentially the stem cell, or chemical precursor, of many other cannabinoids, and is present in virtually all cannabis plants in their early stages of flower. As the plants mature, CBG morphs into any number of the 113 currently known cannabinoids, such as THC and CBD.
After nearly three years of research and development, we were able to isolate and breed strains with unprecedented amounts of CBG. The most exciting aspect about our new lines of CBG seeds are that they show almost no detectable THC, opening them up for production across the nation and the world.
As public awareness builds, and scientific research continues, we expect CBG to become as popular as CBD.